Eli Lilly and Company

(NYSE:LLY)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Operating revenue
Total Revenue 5,209,500 5,150,400 4,807,600 5,189,600
Operating Revenue 5,209,500 5,150,400 4,807,600 5,189,600
Adjustments To Revenue
Cost Of Sales 871,900 919,400 833,800 998,000
Cost Of Sales With Depreciation 1,155,200 1,200,900 1,111,300 1,272,800
Gross Operating Profit 4,337,600 4,231,000 3,973,800 4,191,600
Operating Expenses
Research And Development Expenses 953,000 951,500 877,100 953,600
Selling General And Administrative Expenses 1,649,200 1,700,100 1,550,500 1,755,800
Advertising Expenses
Operating Income Before Depreciation 1,735,400 1,579,400 1,546,200 1,482,200
Operating Income
Depreciation 283,300 281,500 277,500 274,800
Depreciation Unreconciled
Amortization
Amortization Of Intangibles
Operating Income After Depreciation 1,452,100 1,297,900 1,268,700 1,207,400
Non Operating Expenses
Interest Expense 44,000 42,600 59,800 60,400
Pre Tax Income -232,800 1,206,300 1,056,300 1,052,300
Income Taxes 232,800 247,500 -8,000 197,900
Minority Interest
Income Before Income Taxes -232,800 1,206,300 1,056,300 1,052,300
Net Income From Continuing Operations -465,600 958,800 1,064,300 854,400
Net Income From Discontinued Operations
Net Income From Total Operations -465,600 958,800 1,064,300 854,400
Non Recurring Events
Extraordinary Income Losses
Income From Cummulated Effect Of Accounting Changes
Income From Tax Loss Carryforward
Other Gains And Losses
Total Net Income -465,600 958,800 1,064,300 854,400
Normalized Income 1,221,800 1,082,700 1,297,000 1,041,600
NetIncome Available For Common -465,600 958,800 1,064,300 854,400
Preferred Dividends
Excise Taxes